🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Fibrosis of Liver

Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement NCT06814990NA1 site📍 Jena Stephanie Gräger · Tests: Cardiac MRI, Blood samples, Echocardiography Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant. NCT06327308Phase 14 sites📍 Besançon📍 Dijon📍 Nancy Centre Hospitalier Universitaire de Besancon · Tests: MRI, Blood sampling Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications NCT07201649NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: a blood test and urine sample collection. Global Research Initiative for Patients Screening on MASH NCT05651724n/a13 sites📍 Brussels📍 Antwerp📍 Prague Julius Clinical An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study NCT06619106n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Cognitive test Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis. NCT06293378NA2 sites📍 Chongqing📍 Chongqing The Second Affiliated Hospital of Chongqing Medical Univers… · Tests: Sulfasalazine enteric-coated tablets, Sulfasalazine enteric-coated tablets, Sulfasalazine enteric-coated tablets, Sulfa… City-Hospital Collaboration for Early Detection of Liver Fibrosis in Primary Care: A Secondary Prevention Project in the Grenoble Health Area NCT07031089n/a2 sites📍 Grenoble📍 Grenoble University Hospital, Grenoble · Tests: Non-interventional study (RIPH category 3) A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA NCT07282353Phase 342 sites📍 Hefei📍 Hefei📍 Hefei Cascade Pharmaceuticals, Inc · Tests: 2mg CS0159, Placebo Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver Fibrosis NCT04429100n/a1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Magnetic Resonance Imaging A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH NCT06419374Phase 3330 sites📍 Birmingham📍 Homewood📍 Chandler Hoffmann-La Roche · Tests: Pegozafermin, Placebo Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD NCT05644717Phase 41 site📍 Peshawar Getz Pharma · Tests: Ertugliflozin 5 mg, 15mg Molecular Mechanism of Exercise in Cirrhosis NCT05982769NA1 site📍 Cleveland The Cleveland Clinic · Tests: Endurance Training 3 times per week, Resistance Exercise, Standard of Care Austrian PBC Registry NCT07598669n/a11 sites📍 Klagenfurt📍 Sankt Pölten📍 Salzburg Medical University of Vienna Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C NCT06755632NA2 sites📍 Bobigny📍 Bobigny Assistance Publique - Hôpitaux de Paris · Tests: TROD (rapid diagnostic orientation test) and FibroScan® Digoxin In NASH (CODIN) NCT06588699Phase 22 sites📍 New Haven📍 New Haven Yale University · Tests: Digoxin, Placebo Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function NCT07811687n/a1 site📍 Yangzhou Northern Jiangsu People's Hospital Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients With Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome NCT06814626Phase 32 sites📍 Palermo📍 Bern The Mediterranean Institute for Transplantation and Advance… · Tests: 12-week nutritional intervention with Friliver dispensing, 12-week nutritional intervention with personalized diet, 12-… Affect of Melatonin on Sleep and Cognition in Cirrhosis NCT07046429NA1 site📍 New York Weill Medical College of Cornell University · Tests: Melatonin tablet 3 mg once daily, Thiamine FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy NCT07296458Phase 31 site📍 Xi'an Xijing Hospital of Digestive Diseases · Tests: Fenofibrate, UDCA (Ursodeoxycholic acid) Identification of Liver Fibrosis Biomarkers NCT06819917n/a2 sites📍 Copenhagen📍 Mainz Roche Diagnostics GmbH · Tests: Identification of liver fibrosis biomarkers Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study NCT06948565n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon · Tests: observational study Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP) NCT07205874n/a1 site📍 Madrid Hospital Universitario La Paz Spleen Stiffness Measurement for the Detection of Advanced Fibrosis NCT07440511n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS 4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis NCT07554183NA2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: 4D-Flow Liver and heart MRI with Gadolinium injection, Samples Without DNA Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease NCT05309863n/a3 sites📍 Ghent📍 Ghent📍 De Haan University Hospital, Ghent · Tests: Lifestyle management Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: Nucleos(t)ide Analogs (NA) A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) NCT06619561Phase 226 sites📍 Duarte📍 Los Angeles📍 Orange Deciphera Pharmaceuticals, LLC · Tests: Vimseltinib Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma NCT06873269n/a1 site📍 Brussels Universitair Ziekenhuis Brussel · Tests: Baseline assessment, holmium-166 radioembolization, Follow-up phase
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy